Year: 2025
Type: article
Abstract: This article presents a comparative analysis of classical and new oral anticoagulants, highlighting their mechanisms of action, pharmacokinetic properties, clinical applications, advantages, and limitations. Classical anticoagulants, such as warfarin, have been widely used for decades but require regular monitoring and dietary restrictions. In contrast, novel oral anticoagulants (NOACs), including rivaroxaban, apixaban, and dabigatran, offer improved safety profiles, predictable pharmacokinetics, and fewer interactions. The article emphasizes the importance of individualized patient care when choosing the appropriate anticoagulant therapy and outlines current clinical guidelines and research findings related to anticoagulation management.
Authors: Yusupov Ziyodulla Yuldoshevich, Lutfullin Said Irekovich, Rakhmatillaev Rabbonjon Nomoz ugli
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W6949821906
FWCI:
Cites:
Cited by:
Related to: